Brown Technology Innovations

Cancer Medical Device Technology Gains

IECV is working with licensee Theromics Inc. to source a $1.2 million seed equity investment from Launchpad Ventures, New England’s largest angel investment organization.

With anticipated follow-on syndicated investment from two other angel groups of up to $800,000, Theromics is now expected to be able to complete FDA “smart device” regulatory approval and enter the cancer thermal ablation marketplace in early 2022. Brown faculty founders include Dr. Damian Dupuy, Dr. Ed Walsh, and Dr. William Park (emeritus). Launchpad Chairman Hambleton Lord, Brown ’83, has expressed continued interest in having Brown-licensed start-ups join the Launchpad portfolio.​